flucytosine has been researched along with Cross Infection in 26 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Cross Infection: Any infection which a patient contracts in a health-care institution.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifteen neonates diagnosed both clinically and biologically of Candidiasis infection and who were treated with liposomal Amphotericin B from June 1994 through July 1997 were included." | 7.70 | [Neonatal candidiasis and liposomal amphotericin B treatment: our experience]. ( Bejarano Palma, A; Carrasco Sánchez, P; Castillo Montero, ML; Durán de Vargas, L; González-Meneses, A; López Sanz, A; Sáenz Reguera, C; Santano Gallinato, M, 1999) |
| " Therapeutic usage of amphotericin B, the agent of choice for serious Candida infection, is reviewed, along with usage of 5-flucytosine and fluconazole." | 4.78 | Pathogenesis and management of Candida infection syndromes in non-neutropenic patients. ( Solomkin, JS, 1993) |
| "Fifteen neonates diagnosed both clinically and biologically of Candidiasis infection and who were treated with liposomal Amphotericin B from June 1994 through July 1997 were included." | 3.70 | [Neonatal candidiasis and liposomal amphotericin B treatment: our experience]. ( Bejarano Palma, A; Carrasco Sánchez, P; Castillo Montero, ML; Durán de Vargas, L; González-Meneses, A; López Sanz, A; Sáenz Reguera, C; Santano Gallinato, M, 1999) |
| "Candidemia is a serious condition associated with high morbidity and mortality and increased healthcare costs in pediatric patients." | 2.47 | Candida infections in non-neutropenic children after the neonatal period. ( Celebi, S; Hacimustafaoglu, M, 2011) |
| " This article reviews recent pertinent data with regard to dosing guidelines, efficacy, and toxicities of available systemic antifungal agents in the newborn." | 2.42 | Antifungal pharmacotherapy for neonatal candidiasis. ( Bliss, JM; Gigliotti, F; Wellington, M, 2003) |
| "Fluconazole resistance was detected in one isolate of C." | 1.33 | Epidemiology of candidemia in a Turkish tertiary care hospital. ( Bakir, M; Barton, R; Cerikcioglu, N; Yagci, A, 2006) |
| "Diagnosis and treatment of fungal infections in medical and surgical intensive care units are controversial issues." | 1.31 | [Fungal infections in intensive care units: a cross-survey]. ( Dupont, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.69) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trpković, A | 1 |
| Pekmezović, M | 1 |
| Barać, A | 1 |
| Crnčević Radović, L | 1 |
| Arsić Arsenijević, V | 1 |
| Araujo Ribeiro, M | 1 |
| Alastruey-Izquierdo, A | 1 |
| Gomez-Lopez, A | 1 |
| Rodriguez-Tudela, JL | 1 |
| Cuenca-Estrella, M | 1 |
| Krishnan, S | 1 |
| Ostrosky-Zeichner, L | 1 |
| Hacimustafaoglu, M | 1 |
| Celebi, S | 1 |
| Sun, W | 1 |
| Su, J | 1 |
| Xu, S | 1 |
| Yan, D | 1 |
| Oberoi, JK | 1 |
| Wattal, C | 1 |
| Goel, N | 1 |
| Raveendran, R | 1 |
| Datta, S | 1 |
| Prasad, K | 1 |
| Zer, Y | 1 |
| Balci, I | 1 |
| Meriç, G | 1 |
| Olver, WJ | 1 |
| James, SA | 1 |
| Lennard, A | 1 |
| Galloway, A | 1 |
| Roberts, IN | 1 |
| Boswell, TC | 1 |
| Russell, NH | 1 |
| Bliss, JM | 1 |
| Wellington, M | 1 |
| Gigliotti, F | 1 |
| Ahuja, SR | 1 |
| Karande, S | 1 |
| Kulkarni, MV | 1 |
| Tendolkar, U | 1 |
| Bakir, M | 1 |
| Cerikcioglu, N | 1 |
| Barton, R | 1 |
| Yagci, A | 1 |
| Pfaller, MA | 2 |
| Messer, SA | 1 |
| Hollis, RJ | 2 |
| Solomkin, JS | 1 |
| Dubé, MP | 1 |
| Heseltine, PN | 1 |
| Rinaldi, MG | 1 |
| Evans, S | 1 |
| Zawacki, B | 1 |
| St Georgiev, V | 2 |
| Darras-Joly, C | 1 |
| Veber, B | 1 |
| Bedos, JP | 1 |
| Gachot, B | 1 |
| Regnier, B | 1 |
| Wolff, M | 1 |
| Zhang, J | 1 |
| Carrasco Sánchez, P | 1 |
| Castillo Montero, ML | 1 |
| Bejarano Palma, A | 1 |
| López Sanz, A | 1 |
| Santano Gallinato, M | 1 |
| Sáenz Reguera, C | 1 |
| Durán de Vargas, L | 1 |
| González-Meneses, A | 1 |
| St-Germain, G | 1 |
| Laverdière, M | 1 |
| Pelletier, R | 1 |
| Bourgault, AM | 1 |
| Libman, M | 1 |
| Lemieux, C | 1 |
| Noël, G | 1 |
| Krcmery, V | 1 |
| Jurga, L | 1 |
| Mateicka, F | 1 |
| Sulcová, M | 1 |
| Dupont, H | 1 |
| Noone, P | 1 |
| Beale, DF | 1 |
| Pollock, SS | 1 |
| Perera, MR | 1 |
| Amirak, ID | 1 |
| Fernando, ON | 1 |
| Moorhead, JF | 1 |
| Harms, K | 1 |
| Herting, E | 1 |
| Schiffmann, JH | 1 |
| Speer, CP | 1 |
| Reid, M | 1 |
| Rollins, N | 1 |
| Halliday, H | 1 |
| McClure, G | 1 |
| Lequien, P | 1 |
| Dubos, JP | 1 |
| Zaoui, C | 1 |
| Thieuleux, M | 1 |
| Bouchez, MC | 1 |
| Kacet, N | 1 |
| Duquennoy, C | 1 |
| Pierrat, V | 1 |
6 reviews available for flucytosine and Cross Infection
| Article | Year |
|---|---|
Candida infections in non-neutropenic children after the neonatal period.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheter-Related Infections; Child; Cross In | 2011 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Flucona | 2003 |
Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Topics: Amphotericin B; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazole; Flucytosine; Fu | 1993 |
Opportunistic/nosocomial infections. Treatment and developmental therapeutics. I. Cryptococcosis.
Topics: Amphotericin B; Animals; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Com | 1993 |
Opportunistic/nosocomial infections. Treatment and developmental therapeutics. II. Cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Cross Infection; Cryptococcosis; D | 1993 |
Nosocomial cerebral aspergillosis: a report of 3 cases.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Brain; Cross Infection; D | 1996 |
20 other studies available for flucytosine and Cross Infection
| Article | Year |
|---|---|
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross | 2012 |
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; | 2008 |
Invasive candidiasis in the intensive care unit.
Topics: Algorithms; Antifungal Agents; Azoles; Biomarkers; Candidiasis; Chemoprevention; Critical Care; Cros | 2010 |
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cross Infection; DNA, Fungal; DNA, Inter | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; | 2012 |
Identification and antifungal susceptibility of Candida isolated from intensive care unit patients.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Flucytosine; Humans; | 2002 |
Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Carrier State; Cross Infectio | 2002 |
Candida tropicalis meningitis in a young infant.
Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Candidiasis; Cross Infection; Drug Therapy, C | 2003 |
Epidemiology of candidemia in a Turkish tertiary care hospital.
Topics: Amphotericin B; Antifungal Agents; Blotting, Southern; Candida; Candidiasis; Cross Infection; DNA Fi | 2006 |
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
Topics: Amphotericin B; Candida; Candidiasis; Cross Infection; DNA, Fungal; Fluconazole; Flucytosine; Humans | 1995 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluc | 1994 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophores | 1997 |
[Neonatal candidiasis and liposomal amphotericin B treatment: our experience].
Topics: Age Factors; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Body Weight; Candidiasis; Cro | 1999 |
Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Cross Infection; Flucytosine; Humans | 2001 |
Fungaemia in elderly patients.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fl | 2001 |
[Fungal infections in intensive care units: a cross-survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Fluconazole; Flucy | 2001 |
Monitoring aminoglycoside use in patients with severely impaired renal function.
Topics: Aminoglycosides; Carbenicillin; Cross Infection; Drug Interactions; Flucytosine; Humans; Kidney Dise | 1978 |
[Candida infections in premature infants weighing less than 1,500 g. Mucocutaneous colonization and incidence of systemic infections].
Topics: Candidiasis, Chronic Mucocutaneous; Cesarean Section; Cross Infection; Cross-Sectional Studies; Drug | 1992 |
Systemic neonatal candidiasis.
Topics: Amphotericin B; Bacterial Infections; Birth Weight; Candidiasis; Cross Infection; Drug Therapy, Comb | 1991 |
[Neonatal systemic candidiasis].
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Candidiasis; Cross Infection; Flucytosine; H | 1987 |